HUB Investment Partners LLC Boosts Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

HUB Investment Partners LLC boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 68.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,877 shares of the financial services provider’s stock after acquiring an additional 1,165 shares during the period. HUB Investment Partners LLC’s holdings in iShares Biotechnology ETF were worth $380,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at $29,000. HHM Wealth Advisors LLC grew its position in iShares Biotechnology ETF by 200.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 150 shares during the last quarter. VSM Wealth Advisory LLC acquired a new position in iShares Biotechnology ETF in the fourth quarter valued at $30,000. Bradley & Co. Private Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $32,000. Finally, Newbridge Financial Services Group Inc. acquired a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth about $33,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.6 %

Shares of IBB stock opened at $133.58 on Friday. The stock’s 50-day moving average price is $136.23 and its 200 day moving average price is $139.39. The stock has a market capitalization of $6.09 billion, a PE ratio of 27.83 and a beta of 0.77. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57.

iShares Biotechnology ETF Increases Dividend

The business also recently declared a dividend, which was paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th were paid a dividend of $0.1212 per share. The ex-dividend date was Tuesday, March 18th. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.